diltiazem has been researched along with lactic acid in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.67) | 18.7374 |
| 1990's | 17 (70.83) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Elborn, JS; Khan, MM; Nicholls, DP; Riley, M; Stanford, CF | 1 |
| Bracht, A; Ishii-Iwamoto, EL; Yamamoto, NS | 1 |
| Goto, M; Hurley, RM; Lichtenberg, RC; Zeller, WP | 1 |
| Dulchavsky, SA; Geller, ER; Kreis, DJ; Krikhely, M; Maitra, SR | 1 |
| Bonnier, JJ; de Jong, JW; Huizer, T; Troquay, R; van Es, GA | 1 |
| Abiko, Y; Ichihara, K; Nasa, Y | 1 |
| Ishida, Y; Paul, RJ | 1 |
| Watts, JA | 1 |
| Maiorano, L; Watts, J | 1 |
| Abiko, Y; Ichihara, K | 1 |
| Biamino, G; Oeff, M; Schröder, R | 1 |
| Campbell, JD; Paul, RJ | 1 |
| Drourr, N; Geller, ER; Higgins, LD; Maitra, SR | 1 |
| Brecht, C; Brecht, M; de Groot, H | 1 |
| Geller, ER; Maitra, SR; Pan, W | 1 |
| Aomatsu, Y; Fukuoka, T; Hisanaga, M; Horikawa, M; Kanehiro, H; Kido, K; Nakajima, Y; Taki, J; Wada, T; Yoshimura, A | 1 |
| Bracht, A; Ishii-Iwamoto, EL; Kelmer-Bracht, AM; Nishiyama, P | 1 |
| Mandal, TK | 1 |
| Nagao, T; Sato, R; Yamazaki, J | 1 |
| Ikeda, M; Koshika, A; Miyajima, M; Okada, J | 1 |
| Becker, BF; Möbert, J | 1 |
| Bodmeier, R; Kranz, H | 1 |
| Kirby, DS; Lobato, EB; Muehlschlegel, JD; Muehschlegel, JD; Sidi, A | 1 |
2 trial(s) available for diltiazem and lactic acid
| Article | Year |
|---|---|
Comparative effects of epanolol and diltiazem on exercise performance and respiratory gas exchange in angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Benzeneacetamides; Diltiazem; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Humans; Lactates; Lactic Acid; Male; Middle Aged; Oxygen; Propanolamines; Pulmonary Gas Exchange | 1992 |
Myocardial protection by intravenous diltiazem during angioplasty of single-vessel coronary artery disease.
Topics: Adenosine Triphosphate; Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Vessels; Diltiazem; Double-Blind Method; Electrocardiography; Female; Humans; Hypoxanthine; Hypoxanthines; Infusions, Intravenous; Lactates; Lactic Acid; Male; Middle Aged; Myocardium; Randomized Controlled Trials as Topic; Uric Acid | 1990 |
22 other study(ies) available for diltiazem and lactic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Metabolic effects of diltiazem in the perfused rat liver.
Topics: Animals; Atractyloside; Diltiazem; Glucose; In Vitro Techniques; Lactates; Lactic Acid; Liver; Male; Methotrexate; Norepinephrine; Oxygen Consumption; Perfusion; Pyruvates; Pyruvic Acid; Rats; Rats, Inbred Strains | 1992 |
Diltiazem treatment of endotoxic shock in suckling rats.
Topics: Animals; Animals, Newborn; Blood Glucose; Blood Pressure; Diltiazem; Heart Rate; Insulin; Lactates; Lactic Acid; Nitroprusside; Rats; Rats, Inbred Strains; Shock, Septic | 1992 |
Beneficial effects of diltiazem in hemorrhagic shock.
Topics: Animals; Blood Glucose; Blood Pressure; Calcium Channels; Diltiazem; Heart Rate; Lactates; Lactic Acid; Male; Rats; Rats, Inbred Strains; Shock, Hemorrhagic | 1991 |
Both d-cis- and l-cis-diltiazem have anti-ischemic action in the isolated, perfused working rat heart.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Calcium; Coronary Disease; Diltiazem; Fatty Acids, Nonesterified; Heart; Heart Rate; In Vitro Techniques; Lactates; Lactic Acid; Male; Myocardial Reperfusion Injury; Rats; Rats, Inbred Strains; Stereoisomerism | 1990 |
Effects of hypoxia on high-energy phosphagen content, energy metabolism and isometric force in guinea-pig taenia caeci.
Topics: Adenine Nucleotides; Aerobiosis; Animals; Calcium; Carbachol; Diltiazem; Energy Metabolism; Guinea Pigs; Histamine; Hypoxia; Isometric Contraction; Lactates; Lactic Acid; Male; Muscle, Smooth; Oxygen Consumption; Phosphocreatine; Potassium | 1990 |
Protection of ischemic hearts by Ca2+ antagonists.
Topics: Animals; Bepridil; Calcium; Calcium Channel Blockers; Coronary Disease; Diltiazem; Energy Metabolism; Lactates; Lactic Acid; Mitochondria, Heart; Myocardial Contraction; Nifedipine; Pyrrolidines; Rats; Rats, Inbred Strains; Verapamil | 1986 |
Effects of diltiazem upon globally ischemic rat hearts.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Coronary Disease; Diltiazem; Dose-Response Relationship, Drug; Glycolysis; Heart; Heart Rate; Lactates; Lactic Acid; Myocardial Contraction; Myocardium; Rats; Rats, Inbred Strains | 1987 |
Effect of diltiazem, a calcium antagonist, on myocardial pH in ischemic canine heart.
Topics: Adenosine Triphosphate; Animals; Benzazepines; Calcium Channel Blockers; Coronary Disease; Diltiazem; Dogs; Hydrogen-Ion Concentration; Ion Channels; Lactates; Lactic Acid; Myocardium; Phosphocreatine; Propranolol | 1982 |
[Changes in contractility parameters, coronary flow and myocardial oxygen consumption following intravenous diltiazem in patients with coronary heart disease].
Topics: Adult; Aged; Benzazepines; Coronary Circulation; Coronary Disease; Diltiazem; Female; Heart Ventricles; Hemodynamics; Humans; Lactates; Lactic Acid; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption | 1984 |
Effects of diltiazem on force, [Ca2+]i, and energy metabolism in porcine coronary artery.
Topics: Animals; Calcium; Coronary Vessels; Diltiazem; Energy Metabolism; In Vitro Techniques; Lactates; Lactic Acid; Muscle Contraction; Muscle, Smooth, Vascular; Oxygen Consumption; Potassium Chloride; Sodium-Potassium-Exchanging ATPase; Swine | 1993 |
Diltiazem preserves hepatic gluconeogenesis following hemorrhagic shock.
Topics: Animals; Diltiazem; Disease Models, Animal; Gluconeogenesis; Glucose; Isotonic Solutions; Lactates; Lactic Acid; Liver; Male; Perfusion; Pyruvates; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Resuscitation; Ringer's Lactate; Shock, Hemorrhagic | 1993 |
Improvement of the energy status of hypoxic hepatocytes by calcium channel blockers.
Topics: Adenine Nucleotides; Animals; Calcium; Cell Hypoxia; Cell Survival; Cells, Cultured; Diltiazem; Energy Metabolism; Lactates; Lactic Acid; Liver; Male; Nifedipine; Rats; Rats, Wistar | 1993 |
Effect of diltiazem on altered glucose regulation during endotoxic shock.
Topics: Animals; Blood Glucose; Diltiazem; Endotoxins; Gluconeogenesis; Homeostasis; Lactates; Lactic Acid; Liver; Male; Rats; Shock, Septic | 1993 |
Protective effect of the calcium channel blocker diltiazem on hepatic function following warm ischemia.
Topics: Animals; Blood Pressure; Diltiazem; Dogs; Female; Femoral Artery; Hot Temperature; Ischemia; Ketone Bodies; Lactates; Lactic Acid; Liver; Liver Diseases; Male | 1993 |
Concentration dependence of the metabolic effects of diltiazem in the isolated perfused rat liver.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Gluconeogenesis; Glucose; Glycolysis; In Vitro Techniques; Kinetics; Lactic Acid; Liver; Male; Oxygen; Perfusion; Rats; Rats, Wistar | 1996 |
Evaluation of a novel phase separation technique for the encapsulation of water-soluble drugs in biodegradable polymer.
Topics: Adrenergic beta-Antagonists; Antifungal Agents; Antihypertensive Agents; Biodegradation, Environmental; Calcium Channel Blockers; Captopril; Diltiazem; Drug Compounding; Drug Delivery Systems; Evaluation Studies as Topic; Lactic Acid; Metoprolol; Pentamidine; Polyesters; Polyglycolic Acid; Polymers; Solubility; Water | 1998 |
Temporal differences in actions of calcium channel blockers on K+ accumulation, cardiac function, and high-energy phosphate levels in ischemic guinea pig hearts.
Topics: Acidosis; Adenosine Triphosphate; Animals; Calcium Channel Blockers; Depression, Chemical; Diltiazem; Extracellular Space; Guinea Pigs; Heart; Heart Rate; Hydrogen-Ion Concentration; In Vitro Techniques; Lactic Acid; Male; Myocardial Contraction; Myocardial Ischemia; Myocardium; Nifedipine; Phosphocreatine; Potassium; Time Factors; Verapamil | 1999 |
Effect of polymer/basic drug interactions on the two-stage diffusion-controlled release from a poly(L-lactic acid) matrix.
Topics: Biocompatible Materials; Chlorpheniramine; Crystallization; Delayed-Action Preparations; Diffusion; Diltiazem; Drug Interactions; Kinetics; Lactic Acid; Papaverine; Polyesters; Polymers; Verapamil; Water; X-Ray Diffraction | 1999 |
Low-dose calcium antagonists reduce energy demand and cellular damage of isolated hearts during both ischemia and reperfusion.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Coronary Circulation; Diltiazem; Dose-Response Relationship, Drug; Energy Metabolism; Guinea Pigs; Heart; Hemodynamics; In Vitro Techniques; L-Lactate Dehydrogenase; Lactic Acid; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nifedipine; Purines; Pyruvates | 1999 |
A novel in situ forming drug delivery system for controlled parenteral drug delivery.
Topics: Buserelin; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diltiazem; Dimethyl Sulfoxide; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Implants; Emulsions; Kinetics; Lactic Acid; Models, Chemical; Molecular Weight; Particle Size; Pharmaceutical Solutions; Polyesters; Polyglactin 910; Polymers; Porosity; Pyrrolidinones; Solubility; Solvents; Technology, Pharmaceutical | 2007 |
Treating metabolic impairment and myocardial stunning with phosphodiesterase inhibitor type III, milrinone, administered prior to coronary artery occlusion in the presence of calcium channel blockade in pigs.
Topics: Analysis of Variance; Animals; Biomarkers; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Cardiotonic Agents; Coronary Stenosis; Diltiazem; Disease Models, Animal; Heart Rate; Lactic Acid; Milrinone; Myocardial Contraction; Myocardial Reperfusion; Myocardial Stunning; Phosphodiesterase Inhibitors; Research Design; Swine; Time Factors; Vascular Resistance; Ventricular Function, Left; Ventricular Pressure | 2007 |